Global Pharma Briefs: News from Asia, Europe, and the US
By

By
A roundup of news from Germany (Evotec, Secarna Pharmaceuticals, CureVac), Japan (Teva, Takeda), and the US (Astellas, Sorrento Therapeutics, and SRI Biosciences). Germany Evotec, Secarna Pharmaceuticals in Pact for Antisense…

Pharma COVID Roundup: News from Lilly, Pfizer, Amgen, AbbVie, Takeda
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from Eli Lilly and Company, Pfizer, Amgen, AbbVie, Takeda, BioNTech, Novavax, and others. Lilly Initiates Phase III Trial of…

Novartis, Sangamo in $795-M Pact for Gene-Regulation Therapies
By

By
Novartis and Sangamo Therapeutics, a Brisbane, California-based genomic medicine company, have formed a global licensing collaboration agreement, worth up to $795 million, to develop and commercialize gene-regulation therapies to address…

Merck & Co., Hanmi in $870-M Pact for NASH Drug Candidate
By

By
Merck & Co. and Hanmi Pharmaceutical, a Seoul, South Korea-based pharmaceutical company, have formed an exclusive licensing agreement, in a deal worth up to $870 million, for the development, manufacture…

J&J in $1-Bn Supply Pact with US Gov’t for 100-M Doses of COVID-19 Vaccine
By

By
Johnson & Johnson’s (J&J) Janssen Pharmaceutical Companies have entered into a $1-billion agreement with the US government for the large-scale domestic manufacturing and delivery in the US of 100 million…

Sanofi, GSK in $2.1-Bn Pact with US Gov’t for COVID-19 Vaccine
By

By
Sanofi and GlaxoSmithKline (GSK) has formed a $2.1-billion pact with the US government for the development and manufacturing of their COVID-19 vaccine candidate and are in advanced discussions with the…

Pharma COVID Roundup: News from Pfizer, J&J, Gilead, and Genentech
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from Pfizer, J&J, Gilead Sciences, Genentech, Inovio, and Glenmark. US DOJ OKs Info-Sharing on mAb Mfg Among Pharma Companies…

Sanofi, GSK To Supply 60-M Doses of COVID-19 Vaccine to UK Gov’t
By

By
Sanofi and GlaxoSmithKline (GSK) have reached an agreement, subject to a final contract, with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine…

US Gov’t Awards Additional $472 M to Moderna for its COVID Vaccine
By

By
Moderna, a clinical-stage biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, will receive an additional commitment of up to $472 million from the Biomedical Advanced Research and Development Authority…

Kodak Moves into Pharmaceuticals with $765-M Federal Loan
By

By
The US government, through the US International Development Finance Corporation (DFC), has signed a letter of interest to provide a $765-million loan to Eastman Kodak Company to support the launch…